13F Holdings
中文EN

HCAT Health Catalyst, Inc.

Services-Computer Programming, Data Processing, Etc. · Nasdaq · SEC CIK 1636422 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-13.9%
TTM net income YoY-87.8%
TTM EPS YoY-77.2%
Revenue 3-yr CAGR-2.1%
Net income 3-yr CAGR—

Margins

Gross margin49.1%
Operating margin-65.7%
Net margin-74.2%
FCF margin9.4%
EBITDA margin-48.9%

Returns

ROE-84.6%
ROA-49.0%
ROIC (approx.)-52.7%
Asset turnover0.66x

Leverage & solvency

Liabilities / assets38.7%
Debt / equity0.00x
Current ratio1.70x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.13x
Accruals ratio-55.5%
Payout ratio—
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$311.14M$306.58M$295.94M$276.24M$241.93M
Cost of revenue$159.46M$165.81M$164.10M$143.05M$124.35M
Gross profit$151.68M$140.78M$131.83M$133.19M$117.57M
R&D expense$49.77M$57.95M$72.63M$75.68M$62.73M
SG&A expense$49.56M$56.82M$76.56M$61.70M$85.93M
Operating income-$160.85M-$69.81M-$126.90M-$140.00M-$143.65M
Pretax income-$177.26M-$69.17M-$117.79M——
Income tax$716,000$333,000$356,000-$4.28M-$6.90M
Net income-$177.97M-$69.50M-$118.15M-$137.40M-$153.21M
EBITDA-$110.35M-$28.38M-$84.67M-$91.71M-$106.12M
EPS (basic)-2.55-1.15-2.09-2.56-3.23
EPS (diluted)-2.55-1.15-2.09-2.63-3.23
Weighted avg. shares (diluted)69.90M60.18M56.42M54.08M47.49M
Balance sheet
Cash & equivalents$50.81M$249.65M$106.28M$116.31M$193.23M
Short-term investments$44.92M$142.35M$211.45M$247.18M$251.75M
Receivables$59.13M$57.18M$60.29M$47.97M$48.80M
Current assets$169.31M$465.65M$393.40M$427.80M$508.39M
PP&E, net$33.84M$29.39M$25.71M$25.93M$23.32M
Goodwill$209.07M$259.76M$190.65M$185.98M$169.97M
Intangibles$77.68M$86.05M$73.38M$92.19M$104.79M
Total assets$502.64M$858.93M$701.81M$752.29M$832.10M
Current liabilities$89.57M$325.85M$89.03M$82.51M$93.05M
Short-term debt$1.63M$231.18M$0——
Long-term debt$151.62M$151.18M$228.03M$226.52M$180.94M
Total debt$153.25M$382.36M$228.03M$226.52M$180.94M
Total liabilities$256.86M$493.72M$334.89M$327.28M$310.00M
Shareholders' equity$245.78M$365.21M$366.92M$425.01M$522.10M
Net debt$102.44M$132.72M$121.76M$110.21M-$12.29M
Shares outstanding72.03M64.04M58.30M55.26M52.62M
Cash flow statement
Operating cash flow$731,000$14.56M-$33.08M-$35.27M-$23.12M
Capital expenditure$968,000$1.62M$1.24M$2.17M$10.45M
Free cash flow-$237,000$12.94M-$34.32M-$37.44M-$33.57M
Investing cash flow$36.19M-$22.90M$20.29M-$39.02M-$139.68M
Financing cash flow-$235.78M$151.75M$2.73M-$2.61M$264.08M
Depreciation & amortization$50.50M$41.43M$42.22M$48.30M$37.53M
Stock-based compensation$27.01M$40.13M$55.76M$72.10M$65.14M
Share buybacks$5.00M$0$1.81M$8.39M$0

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.